{'fraction_non_alphanumeric': 0.013888888888888888, 'fraction_numerical': 0.0, 'mean_word_length': 6.25503355704698, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Preimplantation diagnosis for diseases with genetic predisposition and nondisease testing

Preimplantation genetic diagnosis has become a method of choice in genetic practices. The present experience includes thousands of clinical cases of preimplantation genetic diagnosis, demonstrating the safety, accuracy and reliability of the technique and its clinical relevance for those at-risk couples who cannot accept traditional methods for prenatal diagnosis and termination of pregnancy. Most recently, preimplantation genetic diagnosis has been performed for late-onset disorders, such as genetic predisposition to cancers, Alzheimer’s disease and nondisease testing involving human leukocyte antigen typing, never practised in prenatal diagnosis. The review of these developments suggests the clinical usefulness of this new approach for avoiding the birth of children with genetic predisposition to cancers and other late-onset disorders, or preimplanation human leukocyte antigen matching to provide the treatment of the affected siblings requiring bone marrow transplantation.